Y-mAbs Therapeutics
YMAB
$15.50
Share price
5.37%
Change (1 day)
151.22%
Change (1 year)
Categories
Y-mAbs Therapeutics (YMAB) - Net assets
Net assets on the balance sheet as of December 2023 : $0.10 B
According to Y-mAbs Therapeutics
's latest financial reports the company has $0.10 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Y-mAbs Therapeutics - Net assets on balance sheet (from 2017 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $0.10 B | -7.54% |
| 2022-12-31 | $0.10 B | -39.36% |
| 2021-12-31 | $0.18 B | 70.17% |
| 2020-12-31 | $0.10 B | -46.79% |
| 2019-12-31 | $0.19 B | 41.54% |
| 2018-12-31 | $0.14 B | 71.06% |
| 2017-12-31 | $82.15 M | 581.14% |
| 2016-12-31 | $12.06 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.22 B | 121.90% | 🇺🇸 USA |